Wealth Enhancement Advisory Services
GMAB icon

Wealth Enhancement Advisory Services’s Genmab GMAB Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Buy
14,928
+1,067
+8% +$28.4K ﹤0.01% 2828
2026
Q1 		$381K Sell
13,861
-957
-6% -$28.7K ﹤0.01% 2555
2025
Q4 		$490K Buy
14,818
+1,350
+10% +$42.1K ﹤0.01% 2494
2025
Q3 		$440K Buy
13,468
+783
+6% +$19.1K ﹤0.01% 2463
2025
Q2 		$257K Buy
+12,685
New +$260K ﹤0.01% 2766

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wealth Enhancement Advisory Services's GMAB Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Genmab (GMAB) stake by 7.7% in Q2 2026, buying an estimated $28.4K and bringing the position to 14,928 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

Wealth Enhancement Advisory Services first reported a position in GMAB in Q2 2025 and has held it in 5 quarters since. The position peaked at $490K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Wealth Enhancement Advisory Services held 14,928 shares of Genmab worth $433K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 1,067 Genmab shares in Q2 2026, an estimated $28.4K.
  • Genmab made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2828 holding.
  • Wealth Enhancement Advisory Services first reported a position in Genmab in Q2 2025 and has held it in 5 quarters since.
  • Wealth Enhancement Advisory Services's Genmab position peaked at $490K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.